Human E2F2 knockout A549 cell line
Be the first to review this product! Submit a review
|
(0 Publication)
E2F2 KO cell line available to order. KO validated by Next Generation Sequencing. Free of charge wild type control provided.
View Alternative Names
E2F transcription factor 2, E2F2_HUMAN, Transcription factor E2F2, dE2F2
- NGS
Lab
Next Generation Sequencing - Human E2F2 knockout A549 cell line (AB288999)
37 bp deletion after Thr131, 5 bp deletion downstream.
Reactivity data
Product details
Although we aim to provide customers with a homozygous clone, feasibility will be dependent on the biology of the protein. Should only heterozygous edits be achieved, you will be notified of the outcome and be asked to confirm whether the cell line is acceptable. All clones will be accompanied with DNA sequencing data, and the mutation description.
Recommended control: Human wild-type A549 cell line (ab288558). Please note a wild-type cell line is not automatically included with a knockout cell line order, if required please add recommended wild-type cell line at no additional cost using the code WILDTYPE-TMTK1.
We will provide viable cells that proliferate on revival.
This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.
What's included?
Properties and storage information
Gene name
Gene editing type
Gene editing method
Knockout validation
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Handling procedures
Initial handling guidelines
Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.
1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.
Subculture guidelines
- All seeding densities should be based on cell counts gained by established methods.
- A guide seeding density of 2x104 cells/cm2 is recommended.
- Cells should be passaged when they have achieved 80-90% confluence.
- Do not allow the cell density to exceed 7x104 cells/cm2.
Culture medium
F-12K + 10% FBS
Cryopreservation medium
Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
E2F2 functions as a transcriptional activator and repressor controlling genes necessary for DNA synthesis and cell cycle progression. It often associates with retinoblastoma protein (RB1) to form complexes that finely regulate gene transcription. E2F2 not only controls cell proliferation but also influences cell differentiation processes by coordinating the balance between distinct cellular states.
Pathways
E2F2 interacts with key players in the cell cycle such as cyclins and cyclin-dependent kinases (CDKs). It is an integral part of the Rb-E2F signaling pathway which governs cell cycle checkpoints and progression. This pathway's regulation heavily influences the activities of other E2F family members such as E2F1 and E2F3 which can either promote or inhibit cell cycle transitions in response to various signals.
Quality control
STR analysis
CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX
Cell culture
Biosafety level
EU: 1 US: 1
Adherent/suspension
Adherent
Gender
Male
Complementary Products
Primary Antibodies
AB92506
Anti-STAT1 alpha antibody [EPYR2154]
BOND RX™ Validated|20ul selling size|RabMAb|Recombinant|KO Validated|Advanced Validation
![Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-STAT1 alpha antibody [EPYR2154] (AB92506)](https://content.abcam.com/products/images/stat1-alpha-antibody-epyr2154-ab92506--immunohistochemistry-formalin-pfa-fixed-paraffin-embedded-sections-img449084.jpg)
- 4
- 2
Primary Antibodies
AB318957
Anti-E2F2 antibody [EPR27391-170] - BSA and Azide free
Recombinant|Advanced Validation|RabMAb
![ChIP-sequencing - Anti-E2F2 antibody [EPR27391-170] - BSA and Azide free (AB318957)](https://content.abcam.com/products/images/e2f2-antibody-epr27391-170-bsa-and-azide-free-ab318957--chip-sequencing-img433524.jpg)
- 0
- 0
Primary Antibodies
AB68153
KO Validated|RabMAb|Recombinant|Lab Essentials|20ul selling size|Advanced Validation
![Western blot - Anti-STAT3 antibody [EPR787Y] (AB68153)](https://content.abcam.com/products/images/stat3-antibody-epr787y-ab68153--western-blot-img16701.jpg)
- 4
- 10
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com